Home > Compound List > Compound details
50817-04-4 molecular structure
click picture or here to close

2,3-diaminobutanedioic acid

ChemBase ID: 102594
Molecular Formular: C4H8N2O4
Molecular Mass: 148.11732
Monoisotopic Mass: 148.04840675
SMILES and InChIs

SMILES:
NC(C(N)C(=O)O)C(=O)O
Canonical SMILES:
NC(C(C(=O)O)N)C(=O)O
InChI:
InChI=1S/C4H8N2O4/c5-1(3(7)8)2(6)4(9)10/h1-2H,5-6H2,(H,7,8)(H,9,10)
InChIKey:
PGNYNCTUBKSHHL-UHFFFAOYSA-N

Cite this record

CBID:102594 http://www.chembase.cn/molecule-102594.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2,3-diaminobutanedioic acid
IUPAC Traditional name
aspartic acid, 3-amino-
Synonyms
meso-2,3-Diaminosuccinic acid
meso-α,β-DIAMINOSUCCINIC ACID
2,3-Diaminosuccinic acid
CAS Number
50817-04-4
921-52-8
EC Number
245-500-1
MDL Number
MFCD00151398
PubChem SID
162088709
PubChem CID
287290

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 287290 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 1.1434017  H Acceptors
H Donor LogD (pH = 5.5) -5.9296136 
LogD (pH = 7.4) -6.744719  Log P -5.9113913 
Molar Refractivity 29.5284 cm3 Polarizability 12.41289 Å3
Polar Surface Area 126.64 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
Storage Condition
Room Temperature (15-30°C) expand Show data source
MSDS Link
Download expand Show data source
Purity
95+% expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

MP Biomedicals MP Biomedicals
MP Biomedicals - 02102269 external link
Aspartic acid antagonist.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle